Identification of bioactive compounds from Vaccinium vitis-idaea L. (Lingonberry) as inhibitors for treating KRAS-associated cancer: a computational approach.
Study finds Lingonberry plant compounds with potential to treat KRAS-associated lung cancer, including arbutin, (+)-catechin, and sinapic acid.
- Ilesanmi A et al (2023).
- In Silico Pharmacol.
- PubMed:
- 37915613